350 related articles for article (PubMed ID: 32839869)
1. Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis.
Kawada K; Ohta T; Fukuda H; Hayashi T; Tanaka K; Imai T; Morita Y; Miyamura M
Ann Hematol; 2020 Oct; 99(10):2429-2436. PubMed ID: 32839869
[TBL] [Abstract][Full Text] [Related]
2. Real-World Comparison of Elobixibat and Lubiprostone Treatment in Patients with Chronic Constipation: A Propensity Score-Matched Analysis.
Eguchi T; Yoshizaki T; Ikeoka S; Takagi M; Fujinami M; Matsuda T; Yamaguchi T; Nonaka T; Amioka S; Katayama N; Inoue K; Matsumoto M; Momose K; Sako T; Noda M; Morisawa T; Okada A
Dig Dis; 2021; 39(4):341-350. PubMed ID: 33142288
[TBL] [Abstract][Full Text] [Related]
3. Control of Constipation in Patients Receiving CHOP or CHOP-Like Chemotherapy Regimens for Non-Hodgkin's Lymphoma.
Hayashi H; Suzuki A; Ohata K; Ishihara M; Kubota Y; Kobayashi R; Shibata Y; Nakamura H; Nakamura N; Kitagawa J; Tsurumi H; Shimizu M; Itoh Y
Biol Pharm Bull; 2017; 40(5):698-702. PubMed ID: 28458356
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
Webster LR; Brewer RP; Lichtlen P; Losch-Beridon T; Mareya S; Wang M
Pain Med; 2018 Jun; 19(6):1195-1205. PubMed ID: 29897589
[TBL] [Abstract][Full Text] [Related]
5. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.
Chang L; Chey WD; Imdad A; Almario CV; Bharucha AE; Diem S; Greer KB; Hanson B; Harris LA; Ko C; Murad MH; Patel A; Shah ED; Lembo AJ; Sultan S
Gastroenterology; 2023 Jun; 164(7):1086-1106. PubMed ID: 37211380
[TBL] [Abstract][Full Text] [Related]
6. Opioid-induced constipation.
Gyawali B; Hayashi N; Tsukuura H; Honda K; Shimokata T; Ando Y
Scand J Gastroenterol; 2015; 50(11):1331-8. PubMed ID: 26061717
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacotherapy in Patients with Chronic Constipation].
Kim SJ; Park KS
Korean J Gastroenterol; 2017 Aug; 70(2):64-71. PubMed ID: 28830131
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Adverse Events in Patients with Chronic Constipation Following Lubiprostone Administration.
Eguchi T; Yoshizaki T; Takagi M; Ikeoka S; Hashimura H; Okamoto N; Matsumoto M; Matsuda T; Miura T; Momose K; Otsuka T; Morisawa T; Okada A
Dig Dis; 2021; 39(1):10-15. PubMed ID: 32450563
[TBL] [Abstract][Full Text] [Related]
9. [A retrospective analysis of neurotoxicity induced by vinca alkaloids combined with azole anti-fungal agents in hematological malignancies].
Osato Y; Yokoyama T; Saito Y; Kani R; Hayabe H; Miyamatsu H; Ohyashiki K
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1667-72. PubMed ID: 21996963
[TBL] [Abstract][Full Text] [Related]
10. Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain.
Spierings EL; Brewer RP; Rauck RL; Losch-Beridon T; Mareya SM
Pain Pract; 2017 Mar; 17(3):312-319. PubMed ID: 26990171
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and Comparison of Daiokanzoto and Lubiprostone for Constipation: A Retrospective Cohort Study.
Yoshida A; Hirose T; Kuroda A; Mitsuoka M; Shinoda Y; Mori K; Kawachi Y; Tanaka K; Takeda A; Sugiyama T; Yoshimura T
Biol Pharm Bull; 2019; 42(5):680-684. PubMed ID: 31061310
[TBL] [Abstract][Full Text] [Related]
12. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.
Chang L; Chey WD; Imdad A; Almario CV; Bharucha AE; Diem S; Greer KB; Hanson B; Harris LA; Ko C; Murad MH; Patel A; Shah ED; Lembo AJ; Sultan S
Am J Gastroenterol; 2023 Jun; 118(6):936-954. PubMed ID: 37204227
[TBL] [Abstract][Full Text] [Related]
13. A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.
Cryer B; Katz S; Vallejo R; Popescu A; Ueno R
Pain Med; 2014 Nov; 15(11):1825-34. PubMed ID: 24716835
[TBL] [Abstract][Full Text] [Related]
14. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
Holder RM; Rhee D
Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
[TBL] [Abstract][Full Text] [Related]
15. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Li F; Fu T; Tong WD; Liu BH; Li CX; Gao Y; Wu JS; Wang XF; Zhang AP
Mayo Clin Proc; 2016 Apr; 91(4):456-68. PubMed ID: 27046523
[TBL] [Abstract][Full Text] [Related]
16. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
[TBL] [Abstract][Full Text] [Related]
17. A Randomized, Double-Blind, Placebo-Controlled Trial to Examine the Effectiveness of Lubiprostone on Constipation Symptoms and Colon Transit Time in Diabetic Patients.
Christie J; Shroff S; Shahnavaz N; Carter LA; Harrison MS; Dietz-Lindo KA; Hanfelt J; Srinivasan S
Am J Gastroenterol; 2017 Feb; 112(2):356-364. PubMed ID: 27922028
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Lubiprostone in Patients with Opioid-Induced Constipation: Phase 3 Study Results and Pooled Analysis of the Effect of Concomitant Methadone Use on Clinical Outcomes.
Spierings ELH; Drossman DA; Cryer B; Mazen Jamal M; Losch-Beridon T; Mareya SM; Wang M
Pain Med; 2018 Jun; 19(6):1184-1194. PubMed ID: 29016868
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
Jamal MM; Adams AB; Jansen JP; Webster LR
Am J Gastroenterol; 2015 May; 110(5):725-32. PubMed ID: 25916220
[TBL] [Abstract][Full Text] [Related]
20. Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial.
Morishita D; Tomita T; Mori S; Kimura T; Oshima T; Fukui H; Miwa H
Am J Gastroenterol; 2021 Jan; 116(1):152-161. PubMed ID: 32969946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
